Jianzhong Q. Zhang
No. 11, Xizhimen South Street
Xizhimen, China
Xizhimen, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 216 publications
Commentary on: "Temporary Shedding with Low-Dose Oral Minoxidil Initiation Does Not Preclude Long-Term Benefit: A Retrospective Cohort Study".
Journal: Journal of the American Academy of Dermatology
Published: July 26, 2026
Stapokibart reduces blood eosinophil counts in patients with moderate-to-severe atopic dermatitis: a post-hoc analysis from phase II and phase III clinical trials.
Journal: The Journal of dermatological treatment
Published: July 15, 2026
Stapokibart provides significant improvements in signs and symptoms of atopic dermatitis irrespective of prior systemic treatment: a post-hoc analysis of a phase 3 trial.
Journal: The Journal of dermatological treatment
Published: July 06, 2026
Long-term Efficacy and Safety of Upadacitinib in the Treatment of Alopecia Areata: A Retrospective Study.
Journal: Journal of the American Academy of Dermatology
Published: May 22, 2026
Post-Treatment Residual Ophiasis in Severe Alopecia Areata, Alopecia Totalis/Universalis.
Journal: Journal of the American Academy of Dermatology
Published: May 22, 2026
Efficacy and Safety of Recibokibart, an Interleukin-36 Receptor Antibody, in Generalized Pustular Psoriasis: A Phase 2 Randomized Trial.
Journal: The British journal of dermatology
Published: May 21, 2026
Modified Delphi Consensus Recommendations for the Management of Psoriasis in Asia-Pacific.
Journal: Dermatology and therapy
Published: April 02, 2026
SSGJ-608 in moderate-to-severe plaque psoriasis: a multicenter, randomized, open-label, phase 3 study.
Journal: Frontiers in immunology
Published: February 13, 2026
Safety, tolerability, and pharmacokinetics of CG2001 in Chinese adult male subjects with androgenetic alopecia: a randomized, double-blind, placebo-controlled, single- and multi-doses, phase 1 clinical study.
Journal: The Journal of dermatological treatment
Published: February 02, 2026
HS-20137 for Chinese Moderate-to-Severe Psoriasis: A Randomized, Double-Blinded, Phase 2 Study.
Journal: Dermatology and therapy
Published: January 14, 2026
Rapid Onset of Action and Quality-of-Life Improvements in Chinese Patients with Plaque Psoriasis Treated with Calcipotriol plus Betamethasone Dipropionate Aerosol Foam in a Randomized Phase 3 Trial.
Journal: Dermatology and therapy
Published: January 14, 2026
Clinical characteristics, subtype classification, and prognostic factors of ophiasis: A retrospective study of 150 patients with therapeutic implications.
Journal: Journal of the American Academy of Dermatology
Published: December 09, 2025
Last Updated: 09/26/2026